BioCentury
ARTICLE | Company News

Cleveland BioLabs management update

January 30, 2012 8:00 AM UTC

Cleveland BioLabs Inc. (NASDAQ:CBLI), Buffalo, N.Y. Business: Cancer, Other, Hematology Transitioning: COO Yakov Kogan to interim CEO; he replaces Michael Fonstein, who stepped down as CEO while remai...